Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading Volume – Here’s Why

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) shares saw unusually-high trading volume on Thursday. Approximately 369,784 shares changed hands during mid-day trading, an increase of 278% from the average daily volume of 97,781 shares. The stock last traded at $29.9580 and had previously closed at $29.70.

Wall Street Analyst Weigh In

NBTX has been the topic of several research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nanobiotix in a report on Thursday, October 15th. Guggenheim assumed coverage on Nanobiotix in a research note on Tuesday, September 15th. They issued a “buy” rating and a $64.00 target price for the company. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $46.67.

Nanobiotix Stock Performance

The stock’s 50-day moving average price is $31.18 and its two-hundred day moving average price is $33.93.

About Nanobiotix

Nanobiotix is a biotechnology company developing nanoparticle-based therapies designed to improve the effectiveness of radiotherapy in cancer treatment. The company’s technology uses hafnium oxide nanoparticles that are injected directly into a tumor and activated by ionizing radiation, with the goal of increasing energy deposition within cancer cells while limiting exposure to surrounding tissue.

Nanobiotix’s lead product candidate, NBTXR3, is being evaluated in clinical studies across several cancer types, including locally advanced head and neck cancer and other solid tumors.